1 / 10

Clinical Trial Management System Market worth 1,065.6 Million USD by 2022

The global clinical trial management system market is expected to reach USD 1,065.6 Million by 2022 from USD 534.1 Million in 2016, at a CAGR of 12.6%.

mmvaidya
Download Presentation

Clinical Trial Management System Market worth 1,065.6 Million USD by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Clinical Trial Management System Market worth 1,065.6 Million USD by 2022 https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  2. The report The report "Clinical Trial Management System Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2022", The global CTMS market is expected to reach 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. Browse: 88 market data tables 46 figures 266 pages And in-depth TOC on “Clinical Trial Management System Market” Download The PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=470 The major factors driving the growth of the CTMS market include the significant partnerships between Asian CROs and pharma companies, rising number of clinical trials in both developing and developed nations, availability of advanced and upgraded CTMS solutions, and rising government support for clinical trials in Asian countries. https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  3. The objectives of this study are as follows:. # To define, describe, segment, and forecast the global clinical trial management systems market by type, delivery mode, component, end user, and region. # To provide detailed information regarding the major factors influencing the growth of the global CTMS market (drivers, restraints, opportunities, and challenges) # To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market # To analyze the growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders # To forecast the market value of market segments with respect to the four key regions, namely, North America (US, and Canada), Europe (Germany, UK, France and RoE), Asia Pacific (China, Japan, India and RoAPAC), and the Rest of the World. # To profile the key players in the global CTMS market and comprehensively analyze their market rank and core competencies https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  4. https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.htmlhttps://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  5. The enterprise CTMS segment is estimated to account for the largest share of the CTMS market by type in 2017 The CTMS market is segmented into enterprise CTMS and site CTMS on the basis of type. The enterprise CTMS segment is expected to command the largest share of the global CTMS market in 2017, and is expected to grow at the highest CAGR in the forecast period. Talk to Our Research Experts@ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=470 This is attributed to the widespread adoption of enterprise CTMS by majority of the end users. https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  6. The pharmaceutical and biopharmaceutical companies segment is expected to hold the largest share of the market in 2017 By end user, the CTMS market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is further subsegmented into large pharmaceutical companies and mid-small pharmaceutical companies. The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS market in 2017. The largest share is attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies. https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  7. North America is expected to dominate the CTMS market during the forecast period Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2022). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region. The major players operating in the CTMS market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US). https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  8. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.  https://www.marketsandmarkets.com/Market-Reports/clinical-trial-management-systems-market-470.html

  9. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets

More Related